Vitamin D and estrogen receptor gene polymorphisms and the risk of colorectal cancer in Bulgaria

International Journal of Colorectal Disease

Volumn 22, Issue 4, 2007, Pages 395-400

  Kadiyska, Tanya ^a   Yakulov, Toma ^a   Kaneva, Radka ^a   Nedin, Dimitar ^b   Alexandrova, Alexandrina ^b   Gegova, Antonina ^b   Savov, Alexey ^a   Mitev, Vanio ^c   Kremensky, Ivo ^a  

^a University Hospital of Obstetrics and Gynecology 'Maichin Dom' Bulgaria   (Bulgaria)

^b Queen Giovanna Hospital   (Bulgaria)

^c MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Colon cancer; Estrogen receptor; Microsatell iteinstability; Vitamin D receptor

Indexed keywords

ESTROGEN RECEPTOR ALPHA; VITAMIN D RECEPTOR;

ADULT; AGED; ARTICLE; BULGARIA; CANCER PATIENT; CANCER RISK; COLON CARCINOGENESIS; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; RECEPTOR GENE; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; BULGARIA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; ESTROGEN RECEPTOR ALPHA; ESTROGEN REPLACEMENT THERAPY; FEMALE; GENOTYPE; HUMANS; MICROSATELLITE INSTABILITY; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK; VITAMIN D;

EID: 33847369823     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-006-0163-0     Document Type: Article

References (31)

1. Jemal A, Murray T, Ward E et al (2005) Cancer statistics. CA Cancer J Clin 55(1):10-30
2. Wu JS, Fazio VW (2000) Colon cancer. Dis Colon Rectum 43:1473-1486
3. Danon SH, Valerianova ZDR, Ilcheva M, Dimova IV, Ivanova TZV (2004) Cancer incidence in Bulgaria 2002. National oncological Centre, Bulgaria, pp 11-12
4. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55(2):74-108
5. Lynch HT, de la Chapelle A (1999) Genetic susceptibility to non-polyposis colorectal cancer. J Med Gene 36:801-818
6. Peltomaki P, Vasen HF (1997) Mutations predisposing to hereditary nonpolyposis colorectal cancer, database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 113:146-158
7. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558-561
8. Martinez ME, Willet WC (1998) Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 7:163-168
9. Grodstein F, Newcomb PA, Stampfer MJ (1999) Postmenopausal hormone therapy and the risk of colorectal cancer: A review and meta-analysis. Am J Med 106:574-582
10. Slattery ML, Potter JD, Curtin K et al (2001) Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. Cancer Res 61(1):126-130
11. Breivik RA, Lothe GI, Meling TO, Rognum AL, Borresen-Dale, Gaudernack G (1997) Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer 74:664-667
12. Liel Y, Shany S, Smirnoff P, Schwartz B (1999) Estrogen increases 1,25-dihydroxyvitamin D receptors expression and bioresponse in the rat duodenal mucosa. Endocrinology 140(1):280-285
13. Francavilla A, Di Leo A, Palimeno L et al (1987) Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding non cancerous colonic tissue. Gastroenterology 93:1301-1306
14. Meggouh F, Lointier P, Saez S (1991) Sex steroid and 1,25-dihydroxyvitamin D 3 receptors in human colorectal adenocarcinoma and normal mucosa. Cancer Res 51:1227-1233
15. Hendrikse CW, Jones CE, Donovan IA, Neoptolemos JP, Baker PR (1993) Oestrogen and progesterone receptors in colorectal cancer and human colonic cell lines. Br J Surg 80:636-640
16. Kaklamanos IG, Bathe OF, Franceschi D et al (1999) Expression of receptors for estrogen and progesterone in malignant colonic mucosa as a prognostic factor for patient survival. J Surg Oncol 72:225-229
17. Vandewalle B, Adenis A, Hornez L, Revillon F, Lefebre J (1994) 1,25 Dyhidroxivitamin D 3 receptors in normal and malignant human colorectal tissues. Cancer Let 86:67-73
18. Speer G, Cseh K, Winkler G et al (2001) Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB-2 and EGF receptor in human rectal cancers. Eur J Cancer 37(12):1463-1468
19. Peehl DM, Skowronski RJ, Leung GK, Wong ST, Stamey TA, Feldman D (1994) Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res 54:805-810
20. Shabahang M, Buras RR, Davoodi F, Schumaker LM, Nauta RJ, Evans SR (1993) 1,25-Dihydroxyvitamin D3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 53:3712-3718
21. Flanagan L, Ethier S, and JoEllen W (1997) Vitamin D-induced apoptosis in estrogen independent breast cancer cells and tumours. In: Norman A, Bouillon R, Thomasset M (eds) Vitamin D. Chemistry, biology and clinical applications of the steroid hormone. University of California, Riverside, CA, pp 459-460
22. Ingles SA, Garcia DG, Wang W et al (2000) Vitamin D receptor genotype and breast cancer in Latinas (United States). Cancer Causes Control 11(1):25-30
23. Weiderpass E, Persson I, Melhus H, Wedren S, Kindmark A, Baron JA (2000) Estrogen receptor alpha gene polymorphisms and endometrial cancer risk. Carcinogenesis 21(4):623-627
24. Ingles SA, Ross RK, Yu MC, Irvine RA, La Pera G, Haile RW, Coetzee GA (1997) Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst 89(2):166-170
25. Haussler MR, Whitfield GK, Haussler CA et al (1998) The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J Bone Miner Res 13: 325-349
26. Herrington DM, Howard TD, Brosnihan KB et al (2002) Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105(16):1879-1882
27. Notarnicola M, Gristina R, Messa C et al (2001) Oestrogen receptors and microsatellite instability in colorectal carcinoma patients. Cancer Lett 168(1):65-70
28. Breivik J, Lothe RA, Meling GI, Rognum TO, Borresen-Dale AL, Gaudernack G (1997) Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer 74(6):664-669
29. Kadiyska T, Tzancheva M, Nedin D et al (2003) MLH1 promoter hypermethylation in Bulgarian patients with colorectal cancer. BJMG Balk J Med Genet 6:3-8
30. Ingles SA, Wang J, Coetzee GA, Lee ER, Frankl HD, Haile RW (2001) Vitamin D receptor polymorphisms and risk of colorectal adenomas (United States). Cancer Causes Control 12(7):607-614
31. Kim HS, Newcomb PA, Ulrich CM (2001) Vitamin D receptor polymorphism and the risk of colorectal adenomas: Evidence of interaction with dietary vitamin D and calcium. Cancer Epidemiol Biomarkers Prev 10(8):869-874